SIRT1 and myeloid sarcoma: Furthermore, expression of SIRT1 on peripheral blood mononuclear cells not only differentiated MS subjects from healthy controls but also those with MS relapse (exacerbation) from the ones in remission (stable phase of the disease) [135,136].